2022. Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies. Mediterranean Journal of Hematology and Infectious Diseases. 14, 1 (Jun. 2022), e2022060. DOI:https://doi.org/10.4084/MJHID.2022.060.